|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.010 CNY | -0.99% |
|
-1.96% | -2.15% |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| Market Cap | 24.98B 3.69B 3.24B 3.01B 2.77B 5.2B 355B 5.28B 35.79B 13.98B 175B 13.85B 13.55B 604B | P/E 2026 * |
10.7x | P/E 2027 * | 9.88x |
|---|---|---|---|---|---|
| Enterprise Value | 20.66B 3.05B 2.68B 2.49B 2.29B 4.3B 294B 4.36B 29.6B 11.56B 144B 11.46B 11.21B 500B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.17% | Yield 2027 * | 4.45% |
| 1 day | -0.99% | ||
| 1 week | -1.96% | ||
| Current month | +6.82% | ||
| 1 month | +5.03% | ||
| 3 months | -7.39% | ||
| 6 months | -10.22% | ||
| Current year | -2.15% |
| 1 week | 4.97 |  | 5.23 |
| 1 month | 4.48 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 2024-10-14 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 2023-11-14 |
Wei He
CEO | Chief Executive Officer | 40 | 2022-04-22 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 2008-11-15 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 2020-11-04 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 2012-06-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/7/24 | Buy | 3,025 | 0.0001% | |||
| 6/7/24 | Buy | 152,445 | 0.0039% | |||
| 6/7/24 | Buy | Director | 63,277 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.99% | -1.96% | -8.24% | -9.25% | 3.69B | |
| +1.99% | -0.06% | +18.40% | +103.52% | 98.45B | |
| +0.91% | -0.21% | +44.07% | +145.06% | 53.41B | |
| -1.05% | -3.07% | -0.70% | +250.62% | 22.84B | |
| -1.27% | -1.38% | -14.55% | -19.35% | 8.13B | |
| -5.96% | -5.05% | -33.58% | -35.62% | 7.4B | |
| -0.53% | -4.15% | -13.02% | -29.09% | 6.7B | |
| -0.80% | -1.73% | +19.59% | +28.57% | 6.17B | |
| -0.52% | -2.75% | -1.98% | +21.60% | 5.29B | |
| +0.79% | +0.98% | +17.05% | +18.55% | 3.6B | |
| Average | -0.74% | -2.71% | +2.70% | +47.46% | 21.57B | |
| Weighted average by Cap. | +0.71% | -1.35% | +17.79% | +108.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.08B 22.03B 20.48B 18.8B 35.32B 2,415B 35.86B 243B 95.03B 1,187B 94.14B 92.11B 4,105B | 180B 26.56B 23.33B 21.69B 19.91B 37.4B 2,557B 37.98B 258B 101B 1,257B 99.7B 97.55B 4,347B |
| Net income | 2.36B 348M 306M 284M 261M 490M 33.51B 498M 3.37B 1.32B 16.47B 1.31B 1.28B 56.95B | 2.56B 378M 332M 309M 283M 532M 36.39B 540M 3.66B 1.43B 17.89B 1.42B 1.39B 61.85B |
| Net Debt | -4.32B -638M -560M -521M -478M -899M -61.45B -913M -6.19B -2.42B -30.21B -2.4B -2.34B -104B | -5.04B -745M -654M -608M -558M -1.05B -71.72B -1.07B -7.22B -2.82B -35.26B -2.8B -2.74B -122B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | CN¥5.010 | -0.99% | 23,167,446 |
| 26-07-23 | CN¥5.060 | 0.00% | 28,249,308 |
| 26-07-22 | CN¥5.060 | -0.20% | 40,542,435 |
| 26-07-21 | CN¥5.070 | -1.93% | 42,898,072 |
| 26-07-20 | CN¥5.170 | +1.17% | 45,714,742 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
